Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?
Open Access
- 6 February 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 160, 114345
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/07914-8)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/10414-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88882.376970/2019-01)
This publication has 113 references indexed in Scilit:
- Biological markers of oxidative stress: Applications to cardiovascular research and practiceRedox Biology, 2013
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- Oxidative stress, insulin signaling, and diabetesFree Radical Biology and Medicine, 2011
- Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressLipids, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Oxidized LDL: Diversity, Patterns of Recognition, and PathophysiologyAntioxidants & Redox Signaling, 2010
- The role of oxidized phospholipids in atherosclerosisJournal of Lipid Research, 2009
- Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetesBMC Complementary and Alternative Medicine, 2008
- Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic IndexJournal of Clinical Biochemistry and Nutrition, 2008
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001